POSTER SESSION I Monday, March 24, 2003   —  9:30 AM - 12:00 Noon Exhibit Hall A - C BREAST PATHOLOGY 20 Prediction of Additional Axillary Metastasis of Breast Cancer Following Sentinel Lymph Node Surgery (97) C Changsri, S Prakash, L Sandweiss, S Bose Cedars-Sinai Medical Center; University of California, Los Angeles, Los Angeles, CA 21 Correlation of HER-2/neu Immunostaining Using Computerized Image Analysis with HER-2 Gene Amplification by FISH in Breast Cancer (101) A Ciampa, D Baiyee, G Pihan, B Xu, M Wertheimer, K Edmiston, A Khan University of Massachusetts Medical School, Worcester, MA 22 Gastrointestinal Metastases of Carcinoma of the Breast (102) M Cohn, L Middleton, V Valero, A Sahin UT M. D. Anderson Cancer Center, Houston, TX 23 Evaluation of Angiogenesis in Male Breast Cancer (115) EM Frangou, J Lawson, R Kanthan University of Saskatchewan, Saskatoon, SK, Canada 24 Immunohistochemical Expression of Prostate Specific Antigen in Normal Breast Tissue and Breast Neoplasms (119) S Gokhale, C Albarracin, B Arun, L Middleton, A Sahin U.T. M. D. Anderson Cancer Center, Houston, TX 25 Can nm23 and Stromelysin-3 Expression Predict the Invasive Potential of Extensive Ductal Carcinoma In-Situ? (128) F Gundogan, S George, J Erban, S Sharifi Tufts-New England Medical Center, Boston, MA; Dana Farber Cancer Institute, Boston, MA 26 ki-67 and Cyclin-D1 Immunostaining Aids in Stratifying Atypical Ductal Hyperplasia Diagnosed on Breast Core Biopsy (129) O Hameed, H Mizrachi, V Ghali, P Tartter St. Luke's-Rossevelt Hospital Center, New York, NY; Beth Israel Medical Center, New York, NY 27 Correlation of Circulating Tumor Cells as Detected by RT-PCR with Pathologic Features of Breast Tumors (143) I Jovanovic, R Woodrick, R Goldschmidt, KL Kaul Evanston Northwestern Healthcare/Northwestern University, Evanston, IL 28 Expression Level of Survivin Messenger RNA Correlates with Grade of Ductal Carcinoma In-Situ (DCIS) (148) E Khanafshar, RC-K Chan, A Hever, WS Nichols, S Bose Cedars-Sinai Medical Center, Los Angeles, CA 29 Focal Adhesion Kinase Expression in Invasive Breast Carcinoma (157) AL Lark, CA Livasy, RC Millikan, LG Dressler, DW Cowan, J Tse, DG Little, WG Cance University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC 30 Expression of Maspin Protein in Breast Carcinoma and Correlation with Clinical Outcome (171) P Mecca, J Xiong, CE Sheehan, AB Boguniewicz, JS Ross Albany Medical College, Albany, NY 31 Ductal Versus Lobular Breast Carcinoma: The Influence of Histologic Subtype on Ultrasound Measurement (183) BS Pritt, T Ashikaga, DL Weaver Fletcher Allen Health Care; University of Vermont College of Medicine; Vermont Cancer Center, Burlington, VT 32 Methylation Profiles To Differentiate Benign and Malignant Breast Lesions in Surgical and Cytological Specimens (184) RT Pu, LE Laitala, DP Clark Johns Hopkins Medical Institutions, Baltimore, MD 33 Pleomorphic Lobular Carcinoma In-Situ Versus Intermediate Grade Ductal Carcinoma In-Situ: A Comparative Analysis of Loss of Heterozygosity at BRCA1/17q/21 (187) HS Qureshi, U Raju, M Salama, G Divine, N Tiwari, MJ Worsham Henry Ford Hospital, Detroit, MI 34 Significant Loss of PTEN Protein Expression in Pure Ductal Carcinoma In Situ: An Early Event in Breast Carcinogenesis (189) A Rawal, RA Goldschmidt Evanston Northwestern Healthcare, Evanston, IL 35 Radiofrequency Ablation in Early Breast Cancer: Qualitative and Quantitative Pathologic Evaluation (190) E Resetkova, B Fornage, E Singletary, E Mirza, M Ross, N Sneige University of Texas M.D. Anderson, Houston, TX 36 Cyclin D1 and p27 Expression Correlates with Response to Trastuzumab Therapy in Patients with HER-2-Overexpressing Metastatic Breast Cancer (222) Q Zhai, F Esteva, P Lee, Q Yang, C Qi, A Sahin UT M.D. Anderson Cancer Center, Houston, TX; Northwestern University, Chicago, IL 37 A Subset of Morphologically Identifiable Mammary Myoepithelial Cells Lacks Expression of Corresponding Phenotypic Markers (223) RR Zhang, Y-G Man, BL Strauss, RL Vang, JS Saenger, R Barner, DT Wheeler, CY Liang Armed Forces Institute of Pathology, Washington, DC